Results 31 to 40 of about 569,433 (400)
Background: Despite investigating coronavirus among respiratory tract infected cases is a top priority to prevent further transmission, severe acute respiratory syndrome coronavirus 2 positivity among this group of patients remains unexplored in resource-
Abdi Birhanu+4 more
doaj +1 more source
Background The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) first broke out in Wuhan (China) and subsequently spread worldwide. Chloroquine has been sporadically used in treating SARS-CoV-2 infection.
Xueting Yao+14 more
semanticscholar +1 more source
Secretion of severe acute respiratory syndrome coronavirus 2 in urine [PDF]
Purpose of review Despite the plethora of publications discussing the severe respiratory coronavirus 2 (SARS-CoV-2), evidence of viral secretion in urine is sparse. Recent findings We could identify 34 publications including a total of 2172 patients.
Ursula Lemberger+6 more
openaire +3 more sources
Sinus computed tomography findings in patients with COVID-19
Objective: To analyze computed tomography scans of paranasal sinuses of a series of patients with coronavirus disease 2019, and correlate the findings with the disease.
Daniel Vaccaro Sumi+6 more
doaj +2 more sources
High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2
Severe acute respiratory syndrome coronavirus 2 is the causative agent of the ongoing coronavirus disease pandemic. Initial estimates of the early dynamics of the outbreak in Wuhan, China, suggested a doubling time of the number of infected persons of 6 ...
S. Sanche+5 more
semanticscholar +1 more source
Antibodies at work in the time of severe acute respiratory syndrome coronavirus 2 [PDF]
In view of devastating effects of COVID-19 on human life, there is an urgent need for the licened vaccines or therapeutics for the SARS-CoV-2 infection. Age-old passive immunization with protective antibodies to neutralize the virus is one of the strategies for emergency prophylaxis and therapy for coronavirus disease 2019 (COVID-19).
Sajna, Kuttuvan Valappil, Kamat, Siya
openaire +2 more sources
Introduction: The response to vaccination against the virus that causes severe acute respiratory infection syndrome coronavirus 2 is lower in renal transplant recipients than in the general population.
Camilo Montero+7 more
doaj +1 more source
Clinical Trials of Repurposed Antivirals for SARS-CoV-2 [PDF]
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has prompted the repurposing of drugs on the basis of promising in vitro and therapeutic results with other human coronavirus ...
Martinez, Miguel Angel
core +1 more source
The COVID‐19 pandemic is rapidly spreading worldwide, notably in Europe and North America where obesity is highly prevalent. The relation between obesity and severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) has not been fully documented.
A. Simonnet+9 more
semanticscholar +1 more source
Clotting disorder in severe acute respiratory syndrome coronavirus 2 [PDF]
SummaryThe severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a novel human respiratory viral infection that has rapidly progressed into a pandemic, causing significant morbidity and mortality. Blood clotting disorders and acute respiratory failure have surfaced as the major complications among the severe cases of coronavirus disease 2019 (
Pujhari, Sujit+3 more
openaire +3 more sources